|
|
|
Volumn 25, Issue 4 SUPPL., 1998, Pages 18-22
|
|
Single-agent gemcitabine versus cisplatin/etoposide in patients with inoperable, locally advanced, or metastatic non-small cell lung cancer
a
a
Thoraxklinik
(Germany)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CISPLATIN;
DEXAMETHASONE;
ETOPOSIDE;
GEMCITABINE;
GRANISETRON;
LORAZEPAM;
METOCLOPRAMIDE;
SEROTONIN 3 ANTAGONIST;
ADULT;
AGED;
ALOPECIA;
ANEMIA;
ARTICLE;
CANCER PALLIATIVE THERAPY;
CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG TOLERABILITY;
EUROPE;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKOPENIA;
LUNG METASTASIS;
LUNG NON SMALL CELL CANCER;
MAJOR CLINICAL STUDY;
MALE;
NAUSEA;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TAIWAN;
THROMBOCYTOPENIA;
VOMITING;
ADULT;
AGED;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
DEOXYCYTIDINE;
ETOPOSIDE;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
TREATMENT OUTCOME;
|
|
EID: 0031928917
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (12)
|
|
References (16)
|
